Treatment of skin, skin structure, bone, and joint infections with ceftazidime
- 9 August 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (2) , 67-74
- https://doi.org/10.1016/0002-9343(85)90264-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Imipenem/cilastatin in the treatment of osteomyelitisThe American Journal of Medicine, 1985
- Ceftizoxime: A Beta‐Lactamase‐Stable, Broad‐Spectrum CephalosporinPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Clinical Experience with Cefotaxime in the Treatment of Serious Bone and Joint InfectionsClinical Infectious Diseases, 1982
- A Comparative Evaluation of Moxalactam: Antimicrobial Activity, Pharmacokinetics, Adverse Reactions, and Clinical EfficacyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- Mechanism of Action, Antimicrobial Activity, Pharmacology, Adverse Effects, and Clinical Efficacy of CefotaximePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- The In Vitro Activity, Human Pharmacology, and Clinical Effectiveness of New beta-Lactam AntibioticsAnnual Review of Pharmacology and Toxicology, 1982
- Ceftizoxime compared with cefamandole for treatment of soft tissue infectionsJournal of Antimicrobial Chemotherapy, 1982
- Treatment of acute and chronic osteomyelitis with ceftizoximeJournal of Antimicrobial Chemotherapy, 1982
- Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsJournal of Antimicrobial Chemotherapy, 1981